Latest News and Press Releases

ANN ARBOR, Mich., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has filed New Drug Submissions (NDSs) to Health Canada for NEXLETOL and NEXLIZET, once-daily,...

Avricore Health Inc. (AVCR) releases its third-quarter results.

Ottawa, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The global population health management market size was valued at USD 85.59 billion in 2024 and is predicted to hit around USD 533.83 billion by 2033, a...

TORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- According to the results of a new Ipsos poll conducted on behalf of CanadaHelps, the country's largest online platform for donating and fundraising, more...

TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone solutions and enterprise...

Avricore Health (AVCR) makes a strategic shift to focus on UK market where it expects to take advantage of better market conditions.

STRIVE-ON Data Readout Expected First Calendar Quarter 2025; NDA Submission on Track for 1H Calendar 2025 Completed Corporate Re-Branding, Connecting Company to Rich Scientific Legacy of Grace...

TORONTO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient recruitment and dosing have begun in...

Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Plaque Modification Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...

Avricore earned 8th spot in Deloitte Canada’s 2024 Technology Fast 50™ Companies-to-Watch list, reflecting its significant growth.